Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins

被引:83
作者
MacDonald, HR [1 ]
Silverstein, MJ [1 ]
Mabry, H [1 ]
Moorthy, B [1 ]
Ye, W [1 ]
Epstein, MS [1 ]
Holmes, D [1 ]
Silberman, H [1 ]
Lagios, M [1 ]
机构
[1] Univ So Calif, Keck Sch Med, Norris Canc Ctr, Los Angeles, CA 90033 USA
关键词
ductal carcinoma in situ; margin width; local recurrence risk; treatment failure;
D O I
10.1016/j.amjsurg.2005.06.005
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Margin width has been shown previously to be the most important predictor of local treatment failure after breast conservation for ductal carcinoma in situ (DCIS). Methods: Five variables thought to be associated with local recurrence were evaluated by univariate and multivariate analysis in 455 nonrandomized patients with DCIS treated with excision alone. Results: Multivariate analysis showed that margin width, age, nuclear grade, and tumor size all were independent predictors of local recurrence, with, margin width as the single most important predictor. After adjusting for all other predictors the likelihood of local recurrence for patients with margins less than 10 mm was 5.39 times as much as that for patients with margins of 10 mm, or more (95% confidence interval, 2.68-10.64). Conclusions: Margin width, the distance between DCIS and the closest inked margin, was the single most important predictor of local recurrence. As margin width increases, the risk for local recurrence decreases. (c) 2005 Excerpta Medica Inc. All rights reserved.
引用
收藏
页码:521 / 525
页数:5
相关论文
共 17 条
[1]   Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853 [J].
Bijker, N ;
Peterse, JL ;
Duchateau, L ;
Julien, JP ;
Fentiman, IS ;
Duval, C ;
Di Palma, S ;
Simony-Lafontaine, J ;
de Mascarel, I ;
van de Vijver, MJ .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (08) :2263-2271
[2]   Value of the Van Nuys Prognostic Index in prediction of recurrence of ductal carcinoma in situ after breast-conserving surgery [J].
Boland, GP ;
Chan, KC ;
Knox, WF ;
Roberts, SA ;
Bundred, NJ .
BRITISH JOURNAL OF SURGERY, 2003, 90 (04) :426-432
[3]   LUMPECTOMY COMPARED WITH LUMPECTOMY AND RADIATION-THERAPY FOR THE TREATMENT OF INTRADUCTAL BREAST-CANCER [J].
FISHER, B ;
COSTANTINO, J ;
REDMOND, C ;
FISHER, E ;
MARGOLESE, R ;
DIMITROV, N ;
WOLMARK, N ;
WICKERHAM, DL ;
DEUTSCH, M ;
ORE, L ;
MAMOUNAS, E ;
POLLER, W ;
KAVANAH, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (22) :1581-1586
[4]  
Fisher ER, 1999, CANCER-AM CANCER SOC, V86, P429, DOI 10.1002/(SICI)1097-0142(19990801)86:3<429::AID-CNCR11>3.0.CO
[5]  
2-Y
[6]   Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial [J].
George, WD ;
Houghton, J ;
Austoker, J ;
Bishop, H ;
Cuzick, J ;
Fentiman, IS ;
Forbes, JF ;
Foster, E ;
Ellis, I ;
Leinster, S ;
Spittle, M ;
Joslin, C ;
Stewart, H ;
Baum, M ;
Campbell, R ;
Elston, C ;
Stroner, P ;
Taylor, I ;
Teasdale, C ;
Cooke, T ;
MacPherson, K ;
Priestman, T ;
Sloane, J ;
Houghton, J ;
Williams, N ;
Riley, D ;
Moritz, S ;
Wells, U ;
Bellenger, K ;
Coles, E ;
Chan, J ;
Foster, E ;
Stroner, P ;
MacDonald, C ;
Douglas, A ;
Campbell, R ;
Forbes, JF ;
Wilson, A ;
Hornery, S ;
Lindsay, D .
LANCET, 2003, 362 (9378) :95-102
[7]   Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853 [J].
Julien, JP ;
Bijker, N ;
Fentiman, IS ;
Peterse, JL ;
Delledonne, V ;
Rouanet, P ;
Avril, A ;
Sylvester, R ;
Mignolet, F ;
Bartelink, H ;
Van Dongen, JA .
LANCET, 2000, 355 (9203) :528-533
[8]  
LAGIOS MD, 1989, CANCER, V63, P618, DOI 10.1002/1097-0142(19890215)63:4<618::AID-CNCR2820630403>3.0.CO
[9]  
2-J
[10]   The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast [J].
Neuschatz, AC ;
DiPetrillo, T ;
Steinhoff, M ;
Safaii, H ;
Yunes, M ;
Landa, M ;
Chung, M ;
Cady, B ;
Wazer, DE .
CANCER, 2002, 94 (07) :1917-1924